Literature DB >> 19026394

No evidence for a difference in neuropsychological profile among carriers and noncarriers of the FMR1 premutation in adults under the age of 50.

Jessica Ezzell Hunter1, Emily Graves Allen, Ann Abramowitz, Michele Rusin, Mary Leslie, Gloria Novak, Debra Hamilton, Lisa Shubeck, Krista Charen, Stephanie L Sherman.   

Abstract

The 5' untranslated region of the fragile X mental retardation gene, FMR1, contains a polymorphic CGG repeat. Expansions of this repeat are associated with a spectrum of disorders. Full mutation alleles, repeats >or= 200, are associated with fragile X syndrome. Premutation alleles, repeats of approximately 55-199, are associated with a tremor-ataxia syndrome most commonly in older males and primary ovarian insufficiency in females. However, the neuropsychological impact of carrying a premutation allele is presently unclear in younger adults. In this study, we analyzed neuropsychological scores for 138 males and 506 females ascertained from the general population and from families with a history of fragile X syndrome. Subjects were age 18-50 years and had varying repeat lengths. Neuropsychological scores were obtained from measures of general intelligence, memory, and executive functioning, including attention. Principal component analysis followed by varimax rotation was used to create independent factors for analysis. These factors were modeled for males and females separately via a general linear model that accounted for correlation among related subjects. All models were adjusted for potential confounders, including age at testing, ethnicity, and household income. Among males, no repeat length associations were detected for any factor. Among females, only a significant association with repeat length and self-report attention (p < 0.01) was detected, with premutation carriers self-reporting significantly more attention-related problems compared to noncarriers. No significant interactions between repeat length and age were detected. Overall, these results indicate the lack of a global neuropsychological impact of carrying a premutation allele among adults under the age of 50.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19026394      PMCID: PMC2668066          DOI: 10.1016/j.ajhg.2008.10.021

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  43 in total

1.  The clinical assessment of attention.

Authors:  J M Halperin
Journal:  Int J Neurosci       Date:  1991-06       Impact factor: 2.292

2.  Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers.

Authors:  A Kenneson; F Zhang; C H Hagedorn; S T Warren
Journal:  Hum Mol Genet       Date:  2001-07-01       Impact factor: 6.150

3.  Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X.

Authors:  R J Hagerman; M Leehey; W Heinrichs; F Tassone; R Wilson; J Hills; J Grigsby; B Gage; P J Hagerman
Journal:  Neurology       Date:  2001-07-10       Impact factor: 9.910

4.  Clinical involvement and protein expression in individuals with the FMR1 premutation.

Authors:  F Tassone; R J Hagerman; A K Taylor; J B Mills; S W Harris; L W Gane; P J Hagerman
Journal:  Am J Med Genet       Date:  2000-03-13

5.  Fragile X premutation carriers: characteristic MR imaging findings of adult male patients with progressive cerebellar and cognitive dysfunction.

Authors:  James A Brunberg; Sebastien Jacquemont; Randi J Hagerman; Elizabeth M Berry-Kravis; Jim Grigsby; Maureen A Leehey; Flora Tassone; W Ted Brown; Claudia M Greco; Paul J Hagerman
Journal:  AJNR Am J Neuroradiol       Date:  2002 Nov-Dec       Impact factor: 3.825

6.  Carrier testing in fragile X syndrome: effect on self-concept.

Authors:  A McConkie-Rosell; G A Spiridigliozzi; J A Sullivan; D V Dawson; A M Lachiewicz
Journal:  Am J Med Genet       Date:  2000-06-19

Review 7.  Premature ovarian failure in the fragile X syndrome.

Authors:  S L Sherman
Journal:  Am J Med Genet       Date:  2000

8.  Neuronal intranuclear inclusions in a new cerebellar tremor/ataxia syndrome among fragile X carriers.

Authors:  C M Greco; R J Hagerman; F Tassone; A E Chudley; M R Del Bigio; S Jacquemont; M Leehey; P J Hagerman
Journal:  Brain       Date:  2002-08       Impact factor: 13.501

9.  Reduced FMR1 mRNA translation efficiency in fragile X patients with premutations.

Authors:  Beatrice Primerano; Flora Tassone; Randi J Hagerman; Paul Hagerman; Francesco Amaldi; Claudia Bagni
Journal:  RNA       Date:  2002-12       Impact factor: 4.942

Review 10.  Is there evidence for neuropsychological and neurobehavioral phenotypes among adults without FXTAS who carry the FMR1 premutation? A review of current literature.

Authors:  Jessica Ezzell Hunter; Ann Abramowitz; Michele Rusin; Stephanie L Sherman
Journal:  Genet Med       Date:  2009-02       Impact factor: 8.822

View more
  41 in total

1.  Daily health symptoms of mothers of adolescents and adults with fragile x syndrome and mothers of adolescents and adults with autism spectrum disorder.

Authors:  Leann E Smith; Marsha Mailick Seltzer; Jan S Greenberg
Journal:  J Autism Dev Disord       Date:  2012-09

2.  An fMRI study of the prefrontal activity during the performance of a working memory task in premutation carriers of the fragile X mental retardation 1 gene with and without fragile X-associated tremor/ataxia syndrome (FXTAS).

Authors:  Ryu-ichiro Hashimoto; Kristina C Backer; Flora Tassone; Randi J Hagerman; Susan M Rivera
Journal:  J Psychiatr Res       Date:  2010-05-31       Impact factor: 4.791

Review 3.  The importance of considering all attributes of memory in behavioral endophenotyping of mouse models of genetic disease.

Authors:  Michael R Hunsaker
Journal:  Behav Neurosci       Date:  2012-06       Impact factor: 1.912

Review 4.  Fragile X: leading the way for targeted treatments in autism.

Authors:  Lulu W Wang; Elizabeth Berry-Kravis; Randi J Hagerman
Journal:  Neurotherapeutics       Date:  2010-07       Impact factor: 7.620

5.  Increased prevalence of seizures in boys who were probands with the FMR1 premutation and co-morbid autism spectrum disorder.

Authors:  Weerasak Chonchaiya; Jacky Au; Andrea Schneider; David Hessl; Susan W Harris; Meredith Laird; Yi Mu; Flora Tassone; Danh V Nguyen; Randi J Hagerman
Journal:  Hum Genet       Date:  2011-10-15       Impact factor: 4.132

6.  Prevalence of CGG expansions of the FMR1 gene in a US population-based sample.

Authors:  Marsha Mailick Seltzer; Mei Wang Baker; Jinkuk Hong; Matthew Maenner; Jan Greenberg; Daniel Mandel
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2012-05-22       Impact factor: 3.568

7.  Disassociation between brain activation and executive function in fragile X premutation females.

Authors:  Annie L Shelton; Kim Cornish; Meaghan Clough; Sanuji Gajamange; Scott Kolbe; Joanne Fielding
Journal:  Hum Brain Mapp       Date:  2016-10-14       Impact factor: 5.038

8.  Eye movements reveal impaired inhibitory control in adult male fragile X premutation carriers asymptomatic for FXTAS.

Authors:  Ling M Wong; Naomi J Goodrich-Hunsaker; Yingratana McLennan; Flora Tassone; Melody Zhang; Susan M Rivera; Tony J Simon
Journal:  Neuropsychology       Date:  2014-04-28       Impact factor: 3.295

9.  Co-occurring diagnoses among FMR1 premutation allele carriers.

Authors:  J E Hunter; J K Rohr; S L Sherman
Journal:  Clin Genet       Date:  2010-01-06       Impact factor: 4.438

10.  Fragile X and autism: Intertwined at the molecular level leading to targeted treatments.

Authors:  Randi Hagerman; Gry Hoem; Paul Hagerman
Journal:  Mol Autism       Date:  2010-09-21       Impact factor: 7.509

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.